SCHEMBL23748814

SCHEMBL23748814

O=C(OCCl)C1(c2ccccc2)CCCCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.60
▸ APOBEC3A P31941 3/20 0.59
▸ APOBEC3G Q9HC16 3/20 0.59
▸ HTT P42858 2/20 0.59
▸ SIGMAR1 Q99720 4/20 0.58
▸ MEN1 O00255 3/20 0.58
▸ KMT2A Q03164 3/20 0.58
▸ PRCP P42785 3/20 0.58
▸ ALDH1A1 P00352 4/20 0.57
▸ GAA P10253 1/20 0.57
▸ POLB P06746 1/20 0.57
▸ CYP1A2 P05177 2/20 0.56
▸ CYP3A4 P08684 2/20 0.56
▸ CYP2D6 P10635 2/20 0.56
▸ TMEM97 Q5BJF2 2/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ PKM P14618 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ AKR1C1 Q04828 1/20 0.56
▸ CHRM2 P08172 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23748846 0.98 APOBEC3A (0.61) MAPK1APOBEC3AAPOBEC3GHTTSIGMAR1
SCHEMBL23748809 0.92 OPRM1 (0.56) MAPK1APOBEC3AAPOBEC3GHTTSIGMAR1
SCHEMBL23225664 0.84 OPRM1 (0.73) MAPK1APOBEC3AAPOBEC3GHTTSIGMAR1
SCHEMBL6660823 0.82 OPRM1 (0.75) APOBEC3AAPOBEC3GHTTSIGMAR1PRCP
SCHEMBL27101945 0.80 APOBEC3A (0.59) MAPK1APOBEC3AAPOBEC3GHTTSIGMAR1
SCHEMBL329509 0.79 AKR1C1 (0.68) MAPK1APOBEC3AAPOBEC3GHTTSIGMAR1
SCHEMBL23225663 0.79 OPRM1 (0.75) APOBEC3AAPOBEC3GSIGMAR1PRCPALDH1A1
SCHEMBL24131750 0.78 APOBEC3A (0.60) MAPK1APOBEC3AAPOBEC3GHTTSIGMAR1
SCHEMBL8545254 0.78 AKR1C1 (0.61) MAPK1APOBEC3AAPOBEC3GHTTSIGMAR1
SCHEMBL1038755 0.78 HDAC4 (0.62) MAPK1APOBEC3AAPOBEC3GHTTSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3863629-A1 PRODRUGS OF CGRP ANTAGONISTS Biohaven Pharmaceutical Holding Company Ltd. (US) 2021-08-18 — — EP disclosed
Send feedback